Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pavmed Inc (PAVM)

Pavmed Inc (PAVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,986
  • Shares Outstanding, K 995
  • Annual Sales, $ 3,000 K
  • Annual Income, $ 39,790 K
  • EBIT $ -20 M
  • EBITDA $ -19 M
  • 60-Month Beta 1.10
  • Price/Sales 586.31
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 0.00% (unch)
  • Historical Volatility 233.79%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 1,176.37% on 04/04/25
  • IV Low 0.00% on 01/22/26
  • Expected Move (DTE 0) 0.04 (0.58%)
  • Put/Call Vol Ratio 0.40
  • Today's Volume 14
  • Volume Avg (30-Day) 19
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 800
  • Open Int (30-Day) 821
  • Expected Range 7.29 to 7.37

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -4.80
  • Number of Estimates 1
  • High Estimate -4.80
  • Low Estimate -4.80
  • Prior Year -3.90
  • Growth Rate Est. (year over year) -23.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.00 +83.00%
on 01/02/26
28.44 -61.39%
on 01/21/26
+2.26 (+25.95%)
since 12/22/25
3-Month
6.00 +83.00%
on 01/02/26
28.44 -61.39%
on 01/21/26
-2.04 (-15.67%)
since 10/22/25
52-Week
6.00 +83.00%
on 01/02/26
28.44 -61.39%
on 01/21/26
-6.72 (-37.97%)
since 01/22/25

Most Recent Stories

More News
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard®

NEW YORK , Jan. 21, 2026 /PRNewswire/ -- Lucid Diagnostics Inc.  (Nasdaq: LUCD)  ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics...

LUCD : 1.0700 (-5.31%)
PAVM : 10.98 (-8.88%)
PAVmed Announces Reverse Stock Split

NEW YORK , Dec. 30, 2025 /PRNewswire/ --  PAVmed Inc.  (NASDAQ: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical...

LUCD : 1.0700 (-5.31%)
PAVM : 10.98 (-8.88%)
Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection

Report includes nearly 12,000 patients who underwent Lucid's EsoGuard ® Esophageal DNA Test on samples collected using its EsoCheck ® Esophageal Cell Collection Device

LUCD : 1.0700 (-5.31%)
PAVM : 10.98 (-8.88%)
Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree

Recognized as the leading company in its size category in program honoring the top workplaces across the diagnostics and precision-medicine sectors

LUCD : 1.0700 (-5.31%)
PAVM : 10.98 (-8.88%)
PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results

Veris Health launched commercial phase of strategic partnership and relaunched development of implantable physiological monitor

LUCD : 1.0700 (-5.31%)
PAVM : 10.98 (-8.88%)
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results

Processed 2,841 EsoGuard ® tests and recognized 3Q25 revenue of $1.2 million, ending quarter with over $47 million in proforma cash and extending runway through 2026 and well past upcoming reimbursement...

LUCD : 1.0700 (-5.31%)
PAVM : 10.98 (-8.88%)
PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025

Conference Call and Webcast at 8:30 AM Eastern Time

PAVM : 10.98 (-8.88%)
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025

Conference Call and Webcast at 8:30 AM Eastern Time

LUCD : 1.0700 (-5.31%)
PAVM : 10.98 (-8.88%)
Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit

NEW YORK , Oct. 15, 2025 /PRNewswire/ --  Lucid Diagnostics Inc.  (Nasdaq: LUCD)  ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and...

LUCD : 1.0700 (-5.31%)
PAVM : 10.98 (-8.88%)
PAVmed Subsidiary, Veris Health and The Ohio State University Comprehensive Cancer Center Launch Commercial Phase of Strategic Partnership Agreement

The Veris Cancer Care Platform to be deployed to enhance personalized cancer care in patients undergoing systemic cancer therapy across OSUCCC – James

PAVM : 10.98 (-8.88%)

Business Summary

PAVmed Inc. is a medical device company. Its diversified pipeline of products address unmet clinical needs, which consists of CarpX (TM) to treat carpal tunnel syndrome; NextFlo(TM) and NextCath(TM) a disposable infusion pump; PortIO(TM) and NextCath interventional radiology and Caldus (TM) tissue ablation...

See More

Key Turning Points

3rd Resistance Point 14.09
2nd Resistance Point 13.39
1st Resistance Point 12.19
Last Price 10.98
1st Support Level 10.29
2nd Support Level 9.59
3rd Support Level 8.39

See More

52-Week High 28.44
Fibonacci 61.8% 19.87
Fibonacci 50% 17.22
Fibonacci 38.2% 14.57
Last Price 10.98
52-Week Low 6.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar